J&J Slapped With Another Talc Cancer Verdict As More Claimants Line Up
This article was originally published in The Rose Sheet
Executive Summary
J&J is ordered to pay $55m in damages to a woman who attributes her ovarian cancer to prolonged perineal use of the company's talc-based powders. The decision comes less than three months after a $72m finding against J&J in a similar case tried in the same St. Louis court, but this one may bode more ominously for the firm's prospects in a long line of related cases to come, plaintiff's counsel suggests.
You may also be interested in...
J&J’s Talc Winning Streak Continues With Calif. Mesothelioma Verdict
A California jury sided with J&J Nov. 16 in the first trial over whether alleged asbestos in the firm's talcum powders caused plaintiff's mesothelioma. The verdict could help check what threatens to be a new field of litigation against J&J for alleged talc dangers, and the firm also is gaining momentum in its defense against ovarian cancer claims.
Litigation In Brief: J&J Defending Talc Again In St. Louis Court; P&G Old Spice Suit; More
J&J is back in St. Louis defending its talc powder products against plaintiff claims linking them to ovarian cancer, following costly verdicts against the firm earlier this year in the same court. More litigation updates.
J&J Talc Suit Dismissals: Plaintiffs Lack Causation Thread For Proof Quilt
Following two plaintiff victories and hefty damages awards in a Missouri circuit court earlier this year, J&J succeeded last week in having a pair of talc cancer cases dismissed in New Jersey due to plaintiffs’ lack of compelling causation evidence. With more than 1,000 talc suits against J&J still pending, the relative weight of expert testimonies – and venue – likely will continue to be significant factors in how they play out.